• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带有噻吩基的 π-扩展环金属化配体的钌(II)配合物的光物理性质和光生物活性。

Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.

机构信息

Department of Chemistry , Acadia University , Wolfville , Nova Scotia B4P 2R6 , Canada.

Department of Chemistry and Biochemistry , The University of North Carolina at Greensboro , Greensboro , North Carolina 27402 , United States.

出版信息

Inorg Chem. 2019 Aug 19;58(16):10778-10790. doi: 10.1021/acs.inorgchem.9b01044. Epub 2019 Aug 6.

DOI:10.1021/acs.inorgchem.9b01044
PMID:31386351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6699892/
Abstract

A new family of cyclometalated ruthenium(II) complexes [Ru(N^N)(C^N)] derived from the π-extended benzo[]imidazo[4,5-]quinolone ligand appended with thienyl groups ( = 1-4, compounds -) was prepared and its members were characterized for their chemical, photophysical, and photobiological properties. The lipophilicities of -, determined as octanol-water partition coefficients (log ), were positive and increased with the number of thienyl units. The absorption and emission bands of the C^N compounds were red-shifted by up to 200 nm relative to the analogous Ru(II) diimine systems. All of the complexes exhibited dual emission with the intraligand fluorescence (IL, C^N-based) shifting to lower energies with increasing and the metal-to-ligand charge transfer phosphorescence (MLCT, N^N-based) remaining unchanged. Compounds - exhibited excited state absorption (ESA) profiles consistent with lowest-lying MLCT states when probed by nanosecond transient absorption (TA) spectroscopy with 532 nm excitation and had contributions from IL(C^N) states with 355 nm excitation. These assignments were supported by the lifetimes observed (<10 ns for the IL states and around 20 ns for the MLCT states) as well as a noticeable ESA for with 355 nm excitation that did not occur with 532 nm excitation. Compound was the only member of the family with two MLCT emissive lifetimes (15, 110 ns), and the TA spectra collected with both 355 and 532 nm excitation was assigned to the IL state, which was corroborated by its 4-6 μs lifetime. The ESA for had a rise time of approximately 10 ns and an initial decay of 110 ns, which suggests a possible MLCT-IL excited state equilibrium that results in delayed emission from the MLCT state. Compound was nontoxic toward human skin melanoma cells (SKMEL28) in the dark (EC = >300 μM); - were cytotoxic and yielded EC values between 1 and 20 μM. The photocytotoxicites with visible light ranged from 87 nM with a phototherapeutic index (PI) of 13 for to approximately 1 μM (PI = >267) for . With red light, EC values varied from 270 nM (PI = 21) for to 12 μM for (PI = >25). The larger PIs for , especially with visible light, were attributed to the much lower dark cytotoxicity for this compound. Because the dark cytotoxicity contributes substantially to the observed photocytotoxicity for -, it was not possible to assess whether the IL state of led to a much more potent phototoxic mechanism in the absence of dark toxicity. There was no stark contrast in cellular uptake and accumulation by laser scanning confocal and differential interference contrast microscopy to explain the large differences in dark toxicities between - and . Nevertheless, the study highlights a new family of Ru(II) C^N complexes where π-conjugation beyond a certain point results in low dark cytotoxicity with high photocytotoxicity, opposing the notion that cyclometalated Ru(II) systems are too toxic to be phototherapeutic agents.

摘要

一种新的家族的环金属钌(II )配合物[Ru(N ^ N)(C ^ N)]衍生自π-扩展苯并[]咪唑[4,5-]喹啉配体附加噻吩基(= 1-4 ,化合物-)进行了制备,并对其化学,光物理和光生物性质进行了表征。 ,确定为辛醇-水分配系数(log )为正值,并随噻吩基单元数的增加而增加。 C ^ N 化合物的吸收和发射带相对于类似的 Ru (II )二亚胺系统红移了多达 200 nm 。所有配合物均表现出双重发射,内配体荧光(IL ,基于 C ^ N )向低能量移动,而金属-配体电荷转移磷光(MLCT ,基于 N ^ N )保持不变。化合物-在纳秒瞬态吸收(TA )光谱中用 532nm 激发探测时表现出与最低 MLCT 态一致的激发态吸收(ESA )谱,并且在 355nm 激发时具有 IL (C ^ N )态的贡献。这些分配由观察到的寿命(IL 态<10 ns , MLCT 态约为 20 ns )以及 355nm 激发时化合物的明显 ESA 支持,而 532nm 激发时则没有。该家族中只有成员具有两个 MLCT 发射寿命(15 ,110 ns ),并且用 355nm 和 532nm 激发收集的 TA 光谱被分配给 IL 态,这得到了其 4-6 μs 寿命的证实。 对 进行 ESA 的上升时间约为 10 ns ,初始衰减为 110 ns ,这表明可能存在 MLCT-IL 激发态平衡,从而导致 MLCT 态的延迟发射。化合物对黑暗中的人皮肤黑色素瘤细胞(SKMEL28 )没有毒性(EC > 300 μM);-是细胞毒性的,其 EC 值在 1 和 20 μM 之间。可见光下的光细胞毒性范围从 87 nM (PI = 13 ),用于 到约 1 μM (PI = > 267 ),用于 。用红光时,EC 值从 270 nM (PI = 21 )变为 12 μM (PI = > 25 )。对于 ,PI 值更高,特别是在可见光下,这归因于该化合物在黑暗中的低细胞毒性。由于黑暗细胞毒性对-的光细胞毒性有很大贡献,因此无法评估 IL 态是否会导致在没有黑暗毒性的情况下,光毒性机制更加有效。激光扫描共聚焦和相差显微镜检查没有明显的细胞摄取和积累差异,无法解释-和之间黑暗毒性的巨大差异。尽管如此,该研究还是突出了一类新的 Ru (II ) C ^ N 配合物,其中π-键合超过一定点会导致低黑暗细胞毒性和高光细胞毒性,这与环金属 Ru (II )系统毒性太大而不能用作光疗剂的观点相反。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/54aa4757a75b/nihms-1043550-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/d28a96a573c4/nihms-1043550-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/6f28b64f4491/nihms-1043550-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/0fa6e34983cd/nihms-1043550-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/2ede944829d9/nihms-1043550-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/13f8cee90218/nihms-1043550-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/de8a3b8e470b/nihms-1043550-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/765689ecf411/nihms-1043550-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/8d7faf7e7efb/nihms-1043550-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/a10fc8a4858d/nihms-1043550-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/54aa4757a75b/nihms-1043550-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/d28a96a573c4/nihms-1043550-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/6f28b64f4491/nihms-1043550-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/0fa6e34983cd/nihms-1043550-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/2ede944829d9/nihms-1043550-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/13f8cee90218/nihms-1043550-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/de8a3b8e470b/nihms-1043550-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/765689ecf411/nihms-1043550-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/8d7faf7e7efb/nihms-1043550-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/a10fc8a4858d/nihms-1043550-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b62/6699892/54aa4757a75b/nihms-1043550-f0010.jpg

相似文献

1
Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.带有噻吩基的 π-扩展环金属化配体的钌(II)配合物的光物理性质和光生物活性。
Inorg Chem. 2019 Aug 19;58(16):10778-10790. doi: 10.1021/acs.inorgchem.9b01044. Epub 2019 Aug 6.
2
π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.作为光动力疗法的反向饱和吸收剂和光敏剂的π-扩展异核钌(II)配合物
Inorg Chem. 2017 Mar 20;56(6):3245-3259. doi: 10.1021/acs.inorgchem.6b02624. Epub 2017 Mar 6.
3
Cyclometalated Ruthenium(II) Complexes Derived from α-Oligothiophenes as Highly Selective Cytotoxic or Photocytotoxic Agents.基于 α-寡聚噻吩的钉(II)配合物作为高选择性细胞毒性或光细胞毒性试剂。
Inorg Chem. 2018 Jul 2;57(13):7694-7712. doi: 10.1021/acs.inorgchem.8b00689. Epub 2018 Jun 21.
4
Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.基于 2,3-二苯基苯并[g]喹喔啉的近红外发射杂环阳离子铱配合物作为体外诊断与治疗的光动力治疗试剂。
Dalton Trans. 2017 Jun 27;46(25):8091-8103. doi: 10.1039/c7dt00913e.
5
Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.设计一种具有红光激发和显著提高的光生物活性的三齿杂配钌(II)配合物。
Inorg Chem. 2020 Aug 3;59(15):11193-11204. doi: 10.1021/acs.inorgchem.0c01860. Epub 2020 Jul 23.
6
Predictive Strength of Photophysical Measurements for in Vitro Photobiological Activity in a Series of Ru(II) Polypyridyl Complexes Derived from π-Extended Ligands.源自π-扩展配体的一系列钌(II)多吡啶配合物的光物理测量对体外光生物活性的预测强度。
Inorg Chem. 2019 Mar 4;58(5):3156-3166. doi: 10.1021/acs.inorgchem.8b03223. Epub 2019 Feb 14.
7
Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.β-咔啉配体的 Ir(III)和 Ru(II) 多吡啶配合物的抗癌光动力活性研究进展。
Eur J Med Chem. 2024 Oct 5;276:116618. doi: 10.1016/j.ejmech.2024.116618. Epub 2024 Jun 28.
8
Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.含 BODIPY 取代的 N-杂环卡宾 (NHC) 配体的中性铱 (III) 配合物:合成、光物理、体外治疗光动力疗法和抗菌活性。
Photochem Photobiol Sci. 2019 Oct 9;18(10):2381-2396. doi: 10.1039/c9pp00142e.
9
NIR-Absorbing Ru Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy.含 α-齐聚噻吩的近红外吸收钌配合物在光动力疗法中的应用。
Chembiochem. 2020 Dec 11;21(24):3594-3607. doi: 10.1002/cbic.202000419. Epub 2020 Sep 25.
10
Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.基于 Ru(II) 菲咯啉的寡聚噻吩配合物作为光疗试剂。
Inorg Chem. 2023 Dec 25;62(51):21181-21200. doi: 10.1021/acs.inorgchem.3c03216. Epub 2023 Dec 11.

引用本文的文献

1
Cyclometalated complexes: promising metallodrugs in the battle against cancer.环金属化配合物:抗癌斗争中颇具潜力的金属药物。
RSC Med Chem. 2025 Jul 31. doi: 10.1039/d5md00178a.
2
Ir(III) Half-Sandwich Photosensitizers with a π-Expansive Ligand for Efficient Anticancer Photodynamic Therapy.具有π-扩展配体的 Ir(III) 半三明治光增敏剂用于高效的抗癌光动力治疗。
J Med Chem. 2024 Feb 8;67(3):1783-1811. doi: 10.1021/acs.jmedchem.3c01276. Epub 2024 Jan 30.
3
Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.基于 Ru(II) 菲咯啉的寡聚噻吩配合物作为光疗试剂。

本文引用的文献

1
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.从肿瘤为中心的角度探讨过渡金属配合物和光动力疗法:TLD1433 开发中的挑战、机遇和亮点。
Chem Rev. 2019 Jan 23;119(2):797-828. doi: 10.1021/acs.chemrev.8b00211. Epub 2018 Oct 8.
2
Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.双核铱(III)双三齿配合物的光物理和光生物性质。
Inorg Chem. 2018 Aug 20;57(16):9859-9872. doi: 10.1021/acs.inorgchem.8b00789. Epub 2018 Aug 9.
3
Cyclometalated Ruthenium(II) Complexes Derived from α-Oligothiophenes as Highly Selective Cytotoxic or Photocytotoxic Agents.
Inorg Chem. 2023 Dec 25;62(51):21181-21200. doi: 10.1021/acs.inorgchem.3c03216. Epub 2023 Dec 11.
4
Collagen Hydrolysate Effects on Photodynamic Efficiency of Gallium (III) Phthalocyanine on Pigmented Melanoma Cells.胶原蛋白水解物对镓(III)酞菁对色素性黑色素瘤细胞光动力效率的影响
Gels. 2023 Jun 9;9(6):475. doi: 10.3390/gels9060475.
5
Cobalamin (Vitamin B12) in Anticancer Photodynamic Therapy with Zn(II) Phthalocyanines.钴胺素(维生素 B12)在含锌(II)酞菁的抗肿瘤光动力疗法中的作用。
Int J Mol Sci. 2023 Feb 23;24(5):4400. doi: 10.3390/ijms24054400.
6
High Intrinsic Phosphorescence Efficiency and Density Functional Theory Modeling of Ru(II)-Bipyridine Complexes with π-Aromatic-Rich Cyclometalated Ligands: Attributions of Spin-Orbit Coupling Perturbation and Efficient Configurational Mixing of Singlet Excited States.具有富含π-芳香族环金属化配体的钌(II)-联吡啶配合物的高本征磷光效率及密度泛函理论建模:自旋-轨道耦合微扰和单重激发态有效构型混合的归因
ACS Omega. 2022 Dec 14;7(51):48583-48599. doi: 10.1021/acsomega.2c07276. eCollection 2022 Dec 27.
7
Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.影响光激活钌类抗癌化合物生成单线态氧与配体取代的因素。
Curr Opin Chem Biol. 2022 Jun;68:102143. doi: 10.1016/j.cbpa.2022.102143. Epub 2022 Apr 25.
8
Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.配体内激发态使钌寡聚噻吩配合物在超缺氧极端条件下变成光触发的超级毒素并具有抗癌作用。
J Am Chem Soc. 2022 May 11;144(18):8317-8336. doi: 10.1021/jacs.2c02475. Epub 2022 Apr 28.
9
Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (IL) Excited States.用于近红外光动力疗法的钌光敏剂需要最低能量的三重态配体内(IL)激发态。
J Photochem Photobiol. 2021 Dec;8. doi: 10.1016/j.jpap.2021.100067. Epub 2021 Sep 15.
10
Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments.作为抗癌剂的光活性和发光过渡金属配合物:寻找新型改良癌症治疗方法的指引之光。
Biomedicines. 2022 Mar 1;10(3):578. doi: 10.3390/biomedicines10030578.
基于 α-寡聚噻吩的钉(II)配合物作为高选择性细胞毒性或光细胞毒性试剂。
Inorg Chem. 2018 Jul 2;57(13):7694-7712. doi: 10.1021/acs.inorgchem.8b00689. Epub 2018 Jun 21.
4
Excited-State Decay Pathways of Tris(bidentate) Cyclometalated Ruthenium(II) Compounds.三(双齿)环金属化钌(II)化合物的激发态衰变途径
Inorg Chem. 2017 Nov 6;56(21):13579-13592. doi: 10.1021/acs.inorgchem.7b02321.
5
Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.基于 2,3-二苯基苯并[g]喹喔啉的近红外发射杂环阳离子铱配合物作为体外诊断与治疗的光动力治疗试剂。
Dalton Trans. 2017 Jun 27;46(25):8091-8103. doi: 10.1039/c7dt00913e.
6
Increasing the triplet lifetime and extending the ground-state absorption of biscyclometalated Ir(iii) complexes for reverse saturable absorption and photodynamic therapy applications.提高双环金属化铱(III)配合物的三重态寿命并扩展其基态吸收,用于反饱和吸收和光动力治疗应用。
Dalton Trans. 2016 Oct 18;45(41):16366-16378. doi: 10.1039/c6dt02416e.
7
Excited state decay of cyclometalated polypyridine ruthenium complexes: insight from theory and experiment.环金属化聚吡啶钌配合物的激发态衰变:理论与实验的见解
Dalton Trans. 2016 Sep 21;45(35):13631-47. doi: 10.1039/c6dt01989g. Epub 2016 Jun 23.
8
Organometallic Ru(II) Photosensitizers Derived from π-Expansive Cyclometalating Ligands: Surprising Theranostic PDT Effects.源自π-扩展环金属化配体的有机金属钌(II)光敏剂:惊人的诊疗光动力疗法效果。
Inorg Chem. 2016 Jan 4;55(1):83-95. doi: 10.1021/acs.inorgchem.5b01838. Epub 2015 Dec 16.
9
Sticking and patching: tuning and anchoring cyclometallated ruthenium(II) complexes.粘贴与修补:环金属化钌(II)配合物的调谐与锚定
Dalton Trans. 2015 Jan 28;44(4):1557-70. doi: 10.1039/c4dt02797c.
10
Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models.多吡啶和环金属化钌(II)配合物的比较:针对二维和三维癌症模型的抗癌活性
Chemistry. 2015 Jan 7;21(2):715-25. doi: 10.1002/chem.201404922. Epub 2014 Nov 11.